Clot firmness reduction 30M after maximum clot amplitude after addition of heparinase:LenFr:Pt:Bld:Qn:Thromboelastography

Preferred Label : Clot firmness reduction 30M after maximum clot amplitude after addition of heparinase:LenFr:Pt:Bld:Qn:Thromboelastography;

LOINC status : ACTIVE;

LOINC display name : Clot firmness reduction 30 Min p max clot amplitude heparinase TEG (Bld) [Length fraction];

LOINC long common name : Clot firmness reduction [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude heparinase;

LOINC short name : CF reduc 30M p MA p hep LenFr Bld TEG;

LOINC description : In this assay, the reduction of clot firmness (i.e., clot lysis), is measured 30 minutes after maximum clot amplitude is reached. Heparinase is added prior to starting the assay in order to eliminate interference by any heparin that is in the patient's sample.;

Details

Origin ID

85820-9;

UMLS CUI

C4483337;

Has challenge
- 30 min p max clot amplitude + heparinase [LOINC Challenge]
- addition of heparinase [LOINC Challenge]
- after addition of heparinase [LOINC Challenge]
- after maximum clot amplitude [LOINC Challenge]
- heparinase [LOINC Challenge]
Has component
- Clot [LOINC component]
- Clot firmness [LOINC component]
- Clot firmness reduction [LOINC component]
- Clot firmness reduction^30M after maximum clot amplitude after addition of heparinase [LOINC component]
- Firmness [LOINC component]
Has method
- Thromboelastography [LOINC method]
Has property
- Length fraction [LOINC Property]
Has system
- Blood [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Part of panel
- Thromboelastography after addtion of heparinase panel:-:Pt:Bld:-: [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients